23andMe announces the launch of a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make meaningful discoveries in therapeutics to treat disease.

As federal regulators listened, patients told them of their symptoms – the sleepless nights, the days with uncontrollable tremors or the little struggles simply maintaining their balance. Paul Cannon, 23andMe’s...

Before a medicine reaches pharmacy shelves, it goes through extensive and rigorous evaluation to prove it is safe and effective. We want to shed some light on a few of...

Geneticists from all over the world have converged in San Diego this week as part of the American Society of Human Genetics annual meeting. A team of scientists from 23andMe...

Unlike the flu virus, which the body is generally able to fight off completely, infection with hepatitis C is often chronic.   That means for most of the three to...

The exact causes of Crohn’s disease remain a mystery, but scientists do know that genetic factors play an important part. More than 30 variations have been associated with increased risk...

Not surprisingly, there has been intense interest in the genetics of obesity in recent years.   Obesity is a major health problem, resulting in tens of thousands of premature deaths...